topharmaceuticals are of high standard and are classified primarily as conventional drugs by law. One reason is that during the last 50 years traditional medicine has been kept alive by both medical practitioners and the increasing interest of patients in herbal drugs. The other reason is that shortly after World War II the pharmaceutical industry specialized in and relied on herbal drugs and also developed and supported projects aimed at optimizing the quality of herbal drugs by standardization and scientific basic research. This development was paralleled by an intensified evaluation of herbal drugs and a search for the active principles of phytopreparations.
The fight for the acceptance and registration of phytopharmaceuticals as drugs has been successful. Today in Germany most of the herbal drugs, even mixtures of herbal drugs, are registered as conventional drugs (1) ; this means that they meet the same stringent criteria of quality, efficacy, and safety as synthetic drugs. (13) .
Other trials were performed with the same positive results, e.g., with standardized Ginkgo, Hypericum (St. John's wort), Kava-Kava, Sabal, Urtica, and Echinacea preparations (1).
Forty-four double-blind studies indicate the efficacy of various Ginkgo extracts for the treatment of cognitive disorders. Kleijnen and Knipschild (14) described eight of these studies and determined that they were performed correctly and without methodologic shortcomings. A recently published doubleblind study performed with a Ginkgo extract showed promising results when the extract was applied for the treatment of dementia and, in particular, for Alzheimer disease (15) .
The Hypericum extract, which is now widely used for the treatment of moderate and less severe depression, was investigated in several placebo-controlled double-blind studies (16) . Some of these studies were also performed in parallel with the synthetic psychopharmaceuticals imipramine and maprotiline (17) . Surprisingly, a 6-week treatment with Hypericum extract with one of the synthetic drugs in parallel resulted in the same significant reduction of the Hamilton Depression Anxiety (HAMDA) score values, with the advantage that there were no side effects with the Hypericum medication (17) .
Another accepted use of herbal drugs is for the treatment of benign prostatic hyperplasia. Germans spend approximately 250 million deutsche marks (wholesale price) per year on prostate remedies, whereas in the United States, surgical treatment is the gold standard in urology. In Germany, many urologists believe that treatment should not target primarily benign prostatic hyperplasia as such, but only the associated symptoms, especially the distressing symptoms of obstructive and irritative urination (1) . In the last 10 years, many clinical and pharmacologic studies have confirmed the observations made when extracts of Urtica root, Serenoa repens fruits (saw palmetto), Cucurbita pepo (pumpkin) seeds, and Hypoxis rooperi were used to treat prostate symptoms (1) . The Saba4 Cucurbita, and Hypoxis drugs; sterins; and other lipids have been suggested to be responsible for the antiinflammatory and cell proliferationinhibiting effect of the extracts. Similar positive effects observed with Urtica extracts may be caused by a synergism of polar compounds such as UDA and polysaccharides (18) . In recent years, Echinacea preparations have developed into the best selling herbal immunostimulants for the adjuvant therapy of recurrent infections of the respiratory and urinary tracts and for the prevention and therapy of common colds and flu (19) . Thorough phytochemical investigations have revealed cichoric acid, alkylamides, and polysaccharides to be the putative major active principles responsible for the enhancement effect on the unspecific immune system (7). Six clinical studies performed with Echinacea preparations, reviewed by a meta-analysis, have confirmed the therapeutic efficacy, but further investigations are necessary to find the optimal dosage and application form (20) . The list of herbal drugs that have been intensively investigated in the last 10 years by phytochemists, pharmacologists, and clinicians includes Silybum manianum (milk thistle), Allium sativum (garlic), Viscum album (mistletoe), Piper methysticum (Kava-Kava), Harpagophytum procumbens, Aesculus hippocastanum (horse chestnut), and Valeriana officinalis. Clinical studies have been performed for these phytopreparations (1) .
Other than the clinical proof of efficacy, several new scientific findings have arisen from the many pharmacologic and clinical investigations that have been performed with the various phytopreparations. They provide insight to the mechanism of action of herbal drugs, which in many respects differs from that of synthetic drugs. The (24) . These new findings need a scientific explanation, especially where the mechanisms of action and possible interactions are concerned. There is a general consensus that these described phenomena, which at present have no rationale, must be elucidated by thorough and systematic research at a molecular level.
